Cargando…
Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial
BACKGROUND: This study was conducted to assess the efficacy and safety of the three dose levels of the three-dimensional autologous chondrocyte implantation product chondrosphere® in the treatment of cartilage defects (4–10 cm(2)) of knee joints. We hereby report the safety results for a 36-month po...
Autores principales: | Becher, Christoph, Laute, Volker, Fickert, Stefan, Zinser, Wolfgang, Niemeyer, Philipp, John, Thilo, Diehl, Peter, Kolombe, Thomas, Siebold, Rainer, Fay, Jakob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429514/ https://www.ncbi.nlm.nih.gov/pubmed/28499391 http://dx.doi.org/10.1186/s13018-017-0570-7 |
Ejemplares similares
-
Safety and Efficacy of Matrix-Associated Autologous Chondrocyte
Implantation With Spheroids for Patellofemoral or Tibiofemoral Defects: A 5-Year
Follow-up of a Phase 2, Dose-Confirmation Trial
por: Hoburg, Arnd, et al.
Publicado: (2022) -
A Prospective, Randomized, Open-Label, Multicenter, Phase III Noninferiority Trial to Compare the Clinical Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroid Technology Versus Arthroscopic Microfracture for Cartilage Defects of the Knee
por: Niemeyer, Philipp, et al.
Publicado: (2019) -
Matrix-Associated Autologous Chondrocyte Implantation Is an Effective Treatment at Midterm Follow-up in Adolescents and Young Adults
por: Hoburg, Arnd, et al.
Publicado: (2019) -
Clinical outcome is significantly better with spheroid-based autologous chondrocyte implantation manufactured with more stringent cell culture criteria
por: Eschen, C., et al.
Publicado: (2020) -
Comparison of Hydrogel-Based Autologous Chondrocyte Implantation Versus Microfracture: A Propensity Score Matched-Pair Analysis
por: Niemeyer, Philipp, et al.
Publicado: (2023)